Regulation of the retinoblastoma-E2F pathway by the ubiquitin-proteasome system

Satyaki Sengupta1, R William Henry1

  • 1Department of Biochemistry and Molecular Biology, Michigan State University, East Lansing, MI 48824, USA.

Insights

The retinoblastoma (RB) pathway, crucial for cell cycle control, is regulated by the ubiquitin-proteasome system. This system impacts RB protein levels and influences gene transcription, with disruptions linked to cancer development.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Biology

Background:

  • The retinoblastoma (RB) tumor suppressor family, including p107 and p130, controls cell proliferation by repressing genes essential for the G1 to S phase transition.
  • RB proteins also play roles in cellular growth, pluripotency, and apoptosis, interacting with E2F transcriptional activators.
  • Cyclin/Cyclin-dependent kinase (Cdk) complexes regulate RB/E2F interactions through phosphorylation, controlling target gene transcription.

Purpose of the Study:

  • To review the role of the ubiquitin-proteasome system in regulating the RB-E2F pathway.
  • To highlight recent findings on non-proteolytic functions of the ubiquitin-proteasome system in transcriptional regulation.
  • To discuss the implications of RB pathway dysregulation in cancer.

Main Methods:

  • Literature review of genetic and biochemical studies.
  • Analysis of recent research on ubiquitin-proteasome system involvement.
  • Discussion of implications for cell cycle control and cancer.

Main Results:

  • The ubiquitin-proteasome system proteolytically controls RB-E2F pathway components.
  • Emerging evidence reveals non-proteolytic roles for the ubiquitin-proteasome system in gene regulation.
  • Disruptions in proteasome-mediated targeting of the RB pathway are linked to developmental issues and cancer.

Conclusions:

  • The ubiquitin-proteasome system is a critical regulator of the RB pathway through both proteolytic and non-proteolytic mechanisms.
  • Understanding these regulatory roles is vital for comprehending cell growth, transformation, and cancer.
  • Further research into the non-proteolytic functions could uncover novel therapeutic strategies.

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.9K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

2.9K
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
9.3K
Regulated Protein Degradation02:58

Regulated Protein Degradation

3.4K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
39.0K
The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
2.0K